FC

Fred Colen

North America, Florida, United States, Boca Raton

Description

Fred Colen is the President and CEO at Neovasc. Fred Colen attended RWTH Aachen University.

Investor Profile

Fred Colen has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Post Ipo Equity rounds (top funding stages).
  • Majority of deals are located in The Netherlands.
  • Strong thematic focus on Biotechnology, Health Care, Machinery Manufacturing.

Stage Focus

  • Post Ipo Equity (100%)

Country Focus

  • The Netherlands (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Machinery Manufacturing
  • Medical
  • Medical Device
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Fred Colen frequently co-invest with?

Wellington Partners
Europe, Bayern, Germany, Munich
Co-Investments: 1
Gimv
Europe, Antwerpen, Belgium, Antwerpen
Co-Investments: 1
Invest-NL
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 1
EQT Life Sciences
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 1
Inkef
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 1

Which angels does Fred Colen often collaborate with?

LF
Europe, Vaud, Switzerland, Lausanne
Shared Deals: 1
Dave Marver
North America, Washington, United States, Seattle
Shared Deals: 1
JB
Europe, Vaud, Switzerland, Lausanne
Shared Deals: 1
Shared Deals: 1
GC
Europe, Vaud, Switzerland, Lausanne
Shared Deals: 1
RO
North America, Iowa, United States, Des Moines
Shared Deals: 1
KD
Europe, Vaud, Switzerland
Shared Deals: 1

What are some of recent deals done by Fred Colen?

Onward

Eindhoven, Noord-Brabant, The Netherlands

Onward develops an Implantable Neuro-stimulation System (INS) with real-time motion feedback and uses training tools.

BiotechnologyHealth CareMachinery ManufacturingMedicalMedical DeviceTherapeutics
Post Ipo EquityMar 20, 2024
Amount Raised: $21,875,113